The associations among quantitative spectral CT parameters, Ki-67 expression levels and EGFR mutation status in NSCLC

26Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Dual-energy spectral computed tomography (DESCT) is based on fast switching between high and low voltages from view to view to obtain dual-energy imaging data, and it can generate monochromatic image sets, iodine-based material decomposition images and spectral CT curves. Quantitative spectral CT parameters may be valuable for reflecting Ki-67 expression and EGFR mutation status in non-small-cell lung cancer (NSCLC). We investigated the associations among the quantitative parameters generated in DESCT and Ki-67 expression and EGFR mutation in NSCLC. We studied sixty-five NSCLC patients with preoperative DESCT scans, and their specimens underwent Ki-67 and EGFR evaluations. Statistical analyses were performed to identify the spectral CT parameters for the diagnosis of Ki-67 expression and EGFR mutation status. We found that tumour grade and the slope of the spectral CT curve in the venous phase were the independent factors influencing the Ki-67 expression level, and the area under the curve (AUC) of the slope of the spectral CT curve in the venous phase in the receiver operating characteristic analysis for distinguishing different Ki-67 expression levels was 0.901. Smoking status and the normalized iodine concentration in the venous phase were independent factors influencing EGFR mutation, and the AUC of the two-factor combination for predicting the presence of EGFR mutation was 0.807. These results show that spectral CT parameters may be useful for predicting Ki-67 expression and the presence of EGFR mutation in NSCLC.

References Powered by Scopus

Cancer statistics, 2014

11530Citations
N/AReaders
Get full text

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

5078Citations
N/AReaders
Get full text

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial

4939Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Improving radiation physics, tumor visualisation, and treatment quantification in radiotherapy with spectral or dual-energy CT

32Citations
N/AReaders
Get full text

Dual-energy CT in predicting Ki-67 expression in laryngeal squamous cell carcinoma

20Citations
N/AReaders
Get full text

The Ki-67 Proliferation Index-Related Nomogram to Predict the Response of First-Line Tyrosine Kinase Inhibitors or Chemotherapy in Non-small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor-Mutant Status

11Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lin, L., Cheng, J., Tang, D., Zhang, Y., Zhang, F., Xu, J., … Wu, H. (2020). The associations among quantitative spectral CT parameters, Ki-67 expression levels and EGFR mutation status in NSCLC. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-60445-0

Readers over time

‘20‘21‘22‘230481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

60%

Professor / Associate Prof. 2

20%

Researcher 2

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

57%

Computer Science 1

14%

Nursing and Health Professions 1

14%

Veterinary Science and Veterinary Medic... 1

14%

Save time finding and organizing research with Mendeley

Sign up for free
0